MetaLabs Co Ltd (090370) — Capital Reinvestment Ratio

Latest as of September 2025: 0.15x

MetaLabs Co Ltd (090370) has a Capital Reinvestment Ratio of 0.15x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩2.60 Billion) in capital expenditures (₩384.96 Million). See 090370 equity financing ratio to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.15x
Capex / Operating Cash Flow

Operating Cash Flow

₩2.60 Billion
KRW

Capital Expenditures

₩384.96 Million
KRW

Data as of

Sep 2025
Most recent filing

MetaLabs Co Ltd Capital Reinvestment Ratio (2013–2022)

This chart tracks MetaLabs Co Ltd's Capital Reinvestment Ratio across 4 annual periods. Check 090370 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for MetaLabs Co Ltd (2013–2022)

Year-by-year Capital Reinvestment Ratio for MetaLabs Co Ltd from 2013 to 2022. For live market cap and broader valuation context, see market cap of MetaLabs Co Ltd.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2022 0.73x ₩447.64 Million ₩324.68 Million ▲ +1040.9%
2021 0.06x ₩2.28 Billion ₩144.92 Million ▼ -96.1%
2020 1.63x ₩1.36 Billion ₩2.22 Billion ▲ +9.0%
2013 1.50x ₩2.57 Billion ₩3.84 Billion
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow